Institutional Ownership
Virax Biolabs Group Ltd
CUSIP G9495L125SHS NEWVRAXQ1 2026
13D / 13G Filings
7
Schedule 13D/13G on record
Beneficial Filers
3
Distinct reporting persons
Largest Stake
24.9%
Max % of class reported
Institutional Holders
3
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
7 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Armistice Capital, LLC | 13G | 10.0% | 823.9K | SEC |
| 2 | Oct 29, 2025 | James Foster | 13G/A | 8.3% | 368.6K | SEC |
| 3 | Oct 29, 2025 | James Foster | 13G/A | 7.3% | 319.9K | SEC |
| 4 | Oct 29, 2025 | James Foster | 13G/A | 12.9% | 288.0K | SEC |
| 5 | Oct 29, 2025 | James Foster | 13G | 24.9% | 288.0K | SEC |
| 6 | Nov 14, 2024 | Armistice Capital, LLC | 13G/A | 5.0% | 228.0K | SEC |
| 7 | Feb 14, 2024 | Armistice Capital, LLC | 13G | 10.0% | 230.1K | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Armistice Capital, LLC | 878.8K | $193.2K |
| 2 | Jump Financial, LLC | 40.7K | $9.0K |
| 3 | Osaic Holdings, Inc. | 20 | $4 |